Dr. Reddy's Labs in spotlight after announcing re-launch of Zenatane

Image
Capital Market
Last Updated : Jun 04 2019 | 9:04 AM IST

Dr. Reddy's Laboratories announced the relaunch of Zenatane (lsotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg a therapeutic equivalent generic version of Accutane, approved by the US Food and Drug Administration (USFDA). The product is being launched with an approved Risk Evaluation and Mitigation Strategy (REMS) Program.

GE Power India has been awarded a contract worth Rs 738.3 crore by Aravali Power Company (a Joint venture company of NTPC, Haryana Power Generation Company and Indraprastha Power Generation Company) for Design, Engineering, Civil Work, Supply, Erection and Commissioning of Wet FGD systems along with auxiliaries like Limestone and Gypsum Handling System and Wet Stack on full turnkey basis.

L&T Technology Services said that its promoter, Larsen & Toubro (L&T), plans to sell upto 3.88% stake in L&T Technology Services through offer for sale (OFS). The offer shall take place over two trading days on 4 June 2019 and 6 June 2019. L&T will sell up to 40.34 lakh shares at a floor price of Rs 1,650 each.

Wipro has fixed Friday, 21 June 2019, as the record date for the proposed buyback of shares.

CESC Ventures announced that it has acquired 64.63% stake in Herbolab India for an aggregate amount of Rs 32.17 crore. Herbolab makes ayurvedic medicines and products under the brand name 'Dr. Vaidya's'.

Lemon Tree Hotels announced that the 'Red Fox Hotel, Chandigarh', 102 room property, which was earlier being operated by Carnation Hotels, a subsidiary and management arm of the company has been taken on lease from the owners of the hotel by Fleur Hotels, a material subsidiary of the company and now the hotel is being operated by the company under the same brand.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 04 2019 | 8:43 AM IST

Next Story